Antibody discovery paves way for new therapies against group A streptococcal infections


Researchers at Lund University in Sweden have discovered an antibody with the potential to protect against Strep A infection, as well as a rare form of antibody binding, that leads to an effective immune response against bacteria. The discovery could explain why so many group A strep vaccines have failed.

Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

Previous article

Hormone may help gauge heart health at menopause

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations